Bluestar Adisseo Co
SSE:600299
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Bluestar Adisseo Co
Capital Expenditures
Bluestar Adisseo Co
Capital Expenditures Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Capital Expenditures | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Bluestar Adisseo Co
SSE:600299
|
Capital Expenditures
-¥3.7B
|
CAGR 3-Years
-34%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
-14%
|
|
|
G
|
Grace Fabric Technology Co Ltd
SSE:603256
|
Capital Expenditures
-¥816.6m
|
CAGR 3-Years
-42%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
N/A
|
|
|
Hengli Petrochemical Co Ltd
SSE:600346
|
Capital Expenditures
-¥6.4B
|
CAGR 3-Years
37%
|
CAGR 5-Years
20%
|
CAGR 10-Years
-34%
|
|
|
Satellite Chemical Co Ltd
SZSE:002648
|
Capital Expenditures
-¥2.5B
|
CAGR 3-Years
0%
|
CAGR 5-Years
17%
|
CAGR 10-Years
-28%
|
|
|
G
|
Guangzhou Tinci Materials Technology Co Ltd
SZSE:002709
|
Capital Expenditures
-¥659.1m
|
CAGR 3-Years
44%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-18%
|
|
|
Rongsheng Petrochemical Co Ltd
SZSE:002493
|
Capital Expenditures
-¥31.3B
|
CAGR 3-Years
3%
|
CAGR 5-Years
5%
|
CAGR 10-Years
-24%
|
|
Bluestar Adisseo Co
Glance View
In the bustling corridors of the global animal nutrition industry, Bluestar Adisseo Co. stands out as a vital player, shaping the future of sustainable feeding solutions. Born from the amalgamation of Adisseo Group and China National Bluestar Corporation, this company has positioned itself uniquely, bridging Western ingenuity with Eastern scale. The very heart of its operation beats with the synthesis of amino acids, vitamins, and essential enzymes that enhance livestock nutrition. By optimizing feed efficiency, Bluestar Adisseo doesn’t just help farmers yield healthier poultry and livestock; it also plays a critical role in reducing the environmental footprint associated with conventional farming practices. These nutritional supplements are crafted through advanced biotechnology and chemistry, ensuring precision and efficacy, which are the central pillars supporting the company's expansive revenue streams. Bluestar Adisseo’s business model is a testament to its strategic innovation and operational excellence. The company earns its keep through a diversified portfolio that extends across several continents, tapping into various markets through both direct sales and strategic partnerships. By continuously investing in R&D, Adisseo ensures its products align with evolving agricultural needs and regulatory requirements, thus maintaining a competitive edge. Moreover, the company's robust supply chain infrastructure allows for the efficient delivery of high-quality products to farmers globally, safeguarding its market share. It is this mastery over cost-effective production and logistical excellence, coupled with a commitment to sustainability, that keeps Bluestar Adisseo not only relevant but also thriving in the ever-competitive landscape of global animal nutrition.
See Also
What is Bluestar Adisseo Co's Capital Expenditures?
Capital Expenditures
-3.7B
CNY
Based on the financial report for Dec 31, 2025, Bluestar Adisseo Co's Capital Expenditures amounts to -3.7B CNY.
What is Bluestar Adisseo Co's Capital Expenditures growth rate?
Capital Expenditures CAGR 10Y
-14%
Over the last year, the Capital Expenditures growth was -128%. The average annual Capital Expenditures growth rates for Bluestar Adisseo Co have been -34% over the past three years , -23% over the past five years , and -14% over the past ten years .